Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia or Schizoaffective Disorder”

147 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 147 results

Large-scale testing (Phase 3)Study completedNCT00095524
What this trial is testing

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Who this might be right for
Body Weight ChangeSchizophreniaSchizoaffective Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 300
Not applicableStudy completedNCT00512070
What this trial is testing

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Seattle Institute for Biomedical and Clinical Research 40
Not applicableStudy completedNCT06007105
What this trial is testing

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizotypal Disorder+8 more
London School of Hygiene and Tropical Medicine 425
Early research (Phase 1)Study completedNCT02504476
What this trial is testing

Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective

Who this might be right for
Schizophrenia or Schizoaffective Disorder
Amgen 52
Early research (Phase 1)Study completedNCT01094249
What this trial is testing

A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder

Who this might be right for
SchizophreniaBipolar DisorderPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 9
Large-scale testing (Phase 3)Study completedNCT00641745
What this trial is testing

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sumitomo Pharma America, Inc. 629
Early research (Phase 1)Study completedNCT04779177
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPediatric
Intra-Cellular Therapies, Inc. 26
Large-scale testing (Phase 3)Study completedNCT00159770
What this trial is testing

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Disorders
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 290
Large-scale testing (Phase 3)Study completedNCT00297388
What this trial is testing

How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Testing effectiveness (Phase 2)Study completedNCT03510741
What this trial is testing

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder
Pakistan Institute of Living and Learning 64
Large-scale testing (Phase 3)Ended earlyNCT00660595
What this trial is testing

Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose

Who this might be right for
Schizophrenic Disorders
AstraZeneca 29
Not applicableStudy completedNCT01152697
What this trial is testing

Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic

Who this might be right for
Patient Noncompliance
University Hospitals Cleveland Medical Center 30
Not applicableStudy completedNCT02160249
What this trial is testing

RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)

Who this might be right for
Schizophrenia Spectrum DisorderSchizophreniaSchizoaffective Disorder+1 more
London School of Hygiene and Tropical Medicine 166
Early research (Phase 1)Study completedNCT02091388
What this trial is testing

Bioavailability of LY03004 and Risperdal® Consta®

Who this might be right for
SchizophreniaSchizoaffective Disorder
Luye Pharma Group Ltd. 108
Post-approval studies (Phase 4)Study completedNCT06041646
What this trial is testing

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

Who this might be right for
Bipolar DisorderSchizophreniaAgitation,Psychomotor+2 more
BioXcel Therapeutics Inc 29
Testing effectiveness (Phase 2)Ended earlyNCT03669640
What this trial is testing

Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Hoffmann-La Roche 131
Not applicableStudy completedNCT03630822
What this trial is testing

Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder

Who this might be right for
SchizophreniaBipolar I Disorder
Assistance Publique Hopitaux De Marseille 399
Post-approval studies (Phase 4)Study completedNCT00373672
What this trial is testing

Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwestern University 58
Not applicableEnded earlyNCT06033326
What this trial is testing

Validation of the French Version of the Lithium Knowledge Test (LKT)

Who this might be right for
Patient Treated With Lithium, With Bipolar or Schizo-affective Disorder, Hospitalized in a Psychiatric Ward
University Hospital, Lille 22
Large-scale testing (Phase 3)Study completedNCT00644969
What this trial is testing

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Smoking Cessation
Pfizer 128
Load More Results